ZYG11A and neoplasm: The tumor suppressive partners comprise three highly significant binding components: MIR99AHGlncRNA/PIK3R3, miR-661/ZYG11A, and PPP2R2B/ZNF136 (Figure 3H–M; Supplementary Excel Files S4 and S5).